摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diethyl 3-hydroxy-1,1-difluoropropylphosphonate | 1225194-19-3

中文名称
——
中文别名
——
英文名称
diethyl 3-hydroxy-1,1-difluoropropylphosphonate
英文别名
diethyl 1,1-difluoro-3-hydroxypropylphosphonate;Diethyl (1,1-difluoro-3-hydroxypropyl)phosphonate;3-diethoxyphosphoryl-3,3-difluoropropan-1-ol
diethyl 3-hydroxy-1,1-difluoropropylphosphonate化学式
CAS
1225194-19-3
化学式
C7H15F2O4P
mdl
——
分子量
232.164
InChiKey
HPDINZIWOKSAIS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.6
  • 重原子数:
    14
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    55.8
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    diethyl 3-hydroxy-1,1-difluoropropylphosphonate4-二甲氨基吡啶 、 sodium azide 、 氢气三乙胺 作用下, 以 乙醇二氯甲烷N,N-二甲基甲酰胺 为溶剂, 20.0 ℃ 、413.7 kPa 条件下, 反应 170.5h, 生成 ethyl hydrogen 3-amino-1,1-difluoropropylphosphonate
    参考文献:
    名称:
    NOVEL AROMATIC THIO COMPOUNDS AS RECEPTOR MODULATORS
    摘要:
    本发明涉及新型芳香硫代衍生物,制备它们的方法,含有它们的药物组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。
    公开号:
    US20140171393A1
  • 作为产物:
    描述:
    diethyl 1,1-difluoro-3-butenylphosphonate臭氧 、 sodium tetrahydroborate 、 二甲基硫 作用下, 以 甲醇二氯甲烷 为溶剂, 反应 23.0h, 以60%的产率得到diethyl 3-hydroxy-1,1-difluoropropylphosphonate
    参考文献:
    名称:
    Trimeric purine nucleoside phosphorylase: Exploring postulated one-third-of-the-sites binding in the transition state
    摘要:
    Transition-state analogue inhibitors, immucillins, were reported to bind to trimeric purine nucleoside phosphorylase (PNP) with the stoichiometry of one molecule per enzyme trimer [ Miles, R. W.; Tyler, P. C.; Furneaux, R. H.; Bagdassarian, C. K.; Schramm, V. L. Biochem. 1998, 37, 8615]. In attempts to observe and better understand the nature of this phenomenon we have conducted calorimetric titrations of the recombinant calf PNP complexed with immucillin H. However, by striking contrast to the earlier reports, we have not observed negative cooperativity and we got the stoichiometry of three immucillin molecules per enzyme trimer. Similar results were obtained from fluorimetric titrations, and for other inhibitors bearing features of the transition state. However, we observed apparent cooperativity between enzyme subunits and apparent lower stoichiometry when we used the recombinant enzyme not fully purified from hypoxanthine, which is moped from Escherichia coli cells. Results presented here prove that one-third-of-the-sites binding does not occur for trimeric PNP, and give the highly probable explanation why previous experiments were interpreted in terms of this phenomenon. (C) 2012 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2012.08.045
点击查看最新优质反应信息

文献信息

  • NOVEL COMPOUNDS AS RECEPTOR MODULATORS WITH THERAPEUTIC UTILITY
    申请人:ALLERGAN, INC.
    公开号:US20130157982A1
    公开(公告)日:2013-06-20
    The present invention relates to novel amine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    本发明涉及新型胺衍生物、其制备方法、包含它们的制药组合物以及它们作为调节鞘氨醇-1-磷酸受体的药物的用途。
  • Compounds as receptor modulators with therapeutic utility
    申请人:Allergan, Inc.
    公开号:US08741875B2
    公开(公告)日:2014-06-03
    The present invention relates to novel amine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of sphingosine-1-phosphate receptors.
    本发明涉及新型胺衍生物,其制备过程,包含它们的制药组合物以及它们作为拟调节鞘氨醇-1-磷酸受体的药物的用途。
  • Structural-based design and synthesis of novel 9-deazaguanine derivatives having a phosphate mimic as multi-substrate analogue inhibitors for mammalian PNPs
    作者:Sadao Hikishima、Mariko Hashimoto、Lucyna Magnowska、Agnieszka Bzowska、Tsutomu Yokomatsu
    DOI:10.1016/j.bmc.2010.01.062
    日期:2010.3
    9-(5',5'-Difluoro-5'-phosphonopentyl)-9-deazaguanine (DFPP-DG) was designed as a multi-substrate analogue inhibitor against purine nucleoside phosphorylase (PNP) on the basis of X-ray crystallographic data obtained for a binary complex of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine (DFPP-G) with calf-spleen PNP. DFPP-DG and its analogous compounds were synthesized by the Sonogashira coupling reaction between a 9-deaza-9-iodoguanine derivative and omega-alkynyldifluoromethylene phosphonates as a key reaction. The experimental details focused on the synthetic chemistry along with some insights into the physical and biological properties of newly synthesized DFPP-DG derivatives are disclosed. (C) 2010 Elsevier Ltd. All rights reserved.
  • US8741875B2
    申请人:——
    公开号:US8741875B2
    公开(公告)日:2014-06-03
  • US8828973B2
    申请人:——
    公开号:US8828973B2
    公开(公告)日:2014-09-09
查看更多

同类化合物

(1-氨基丁基)磷酸 顺丙烯基磷酸 除草剂BUMINAFOS 阿仑膦酸 阻燃剂 FRC-1 铵甲基膦酸盐 钠甲基乙酰基膦酸酯 钆1,5,9-三氮杂环十二烷-N,N',N''-三(亚甲基膦酸) 钆-1,4,7-三氮杂环壬烷-N,N',N''-三(亚甲基膦酸) 重氮甲基膦酸二乙酯 辛基膦酸二丁酯 辛基膦酸 辛基-膦酸二钾盐 辛-1-烯-2-基膦酸 试剂12-Azidododecylphosphonicacid 英卡膦酸 苯胺,4-乙烯基-2-(1-甲基乙基)- 苯甲基膦酸二甲酯 苯基膦酸二甲酯 苯基膦酸二仲丁酯 苯基膦酸二乙酯 苯基膦酸二乙酯 苯基磷酸二辛酯 苯基二异辛基亚磷酸酯 苯基(1H-1,2,4-三唑-1-基)甲基膦酸二乙酯 苯丁酸,b-氨基-g-苯基- 苄基膦酸苄基乙酯 苄基亚甲基二膦酸 膦酸,[(2-乙基己基)亚氨基二(亚甲基)]二,triammonium盐(9CI) 膦酸叔丁酯乙酯 膦酸单十八烷基酯钾盐 膦酸二辛酯 膦酸二(二十一烷基)酯 膦酸,辛基-,单乙基酯 膦酸,甲基-,单(2-乙基己基)酯 膦酸,甲基-,二(苯基甲基)酯 膦酸,甲基-,2-甲氧基乙基1-甲基乙基酯 膦酸,丁基乙基酯 膦酸,[苯基[(苯基甲基)氨基]甲基]-,二甲基酯 膦酸,[[羟基(苯基甲基)氨基]苯基甲基]-,二(苯基甲基)酯 膦酸,[2-(环丙基氨基)-2-羰基乙基]-,二乙基酯 膦酸,[2-(二甲基亚肼基)丙基]-,二乙基酯,(E)- 膦酸,[1-甲基-2-(苯亚氨基)乙烯基]-,二乙基酯 膦酸,[1-(乙酰基氨基)-1-甲基乙基]-(9CI) 膦酸,[(环己基氨基)苯基甲基]-,二乙基酯 膦酸,[(二乙氧基硫膦基)(二甲氨基)甲基]- 膦酸,[(2S)-2-氨基-2-苯基乙基]-,二乙基酯 膦酸,[(1Z)-2-氨基-2-(2-噻嗯基)乙烯基]-,二乙基酯 膦酸,P-[(二乙胺基)羰基]-,二乙基酯 膦酸,(氨基二环丙基甲基)-